Longer blood clot prevention after major liver cancer surgery
Part of Blood & lymphatic, Digestive system, Heart & circulation clinical trials.
This study looks at how long the blood stays at a higher risk of clotting after major liver surgery for cancer. It tests whether giving a blood-thinning injection for a longer time after surgery can safely reduce the chance of blood clots. This could help guide recovery care after your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You are scheduled for a major liver surgery (removing more than two sections) to treat cancer.
- You will need to give yourself or have a caregiver give you daily injections to prevent blood clots after surgery.
- You cannot be currently taking blood thinners or antiplatelet drugs.
- You cannot have a history of blood clots, a bleeding or clotting disorder, or a condition like thrombophilia that makes clots more likely.
- You must be able to understand, speak, and read English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This study tests a personalized approach to prevent blood clots in patients who have had surgery to repair blocked arteries in their legs. Researchers want to find the best blood-thinning medication for each individual to reduce serious complications while keeping you safe.
This study compares two approaches to preventing blood clots around the time of liver surgery. If you’re having planned liver surgery, it may help doctors choose the safest timing and method for clot prevention.
This trial tests two ways to prevent blood clots (deep vein thrombosis and pulmonary embolism) after colorectal cancer surgery. The study aims to find out if a new method is as good as the standard one, which could help reduce the risk of these serious complications.
This trial tests whether a pill (dabigatran) or a daily injection (enoxaparin) is better at preventing new blood clots in the liver vein for people with cirrhosis. Both are blood thinners, and the study wants to see which one is safer and more effective.
Hear when a new Surgery-Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.